Comparison of Balance and Coordination Parameters of Visually Impaired and Healthy Individuals

November 12, 2024 updated by: Alper Percin, Bahçeşehir University

The Comparison of Balance and Coordination Between Visually Impaired and Healthy Sedentary Individuals

The aim of this [observational study] is to examine balance in multiple aspects by comparing balance, coordination, and gait parameters between congenitally blind individuals and healthy individuals with multiple scales.

The main questions it aims to answer are:

Is there a difference in balance and coordination between congenitally blind individuals and healthy individuals? comparison group: Healthy sedated individuals Participants will be asked to complete balance scales.

Study Overview

Status

Completed

Conditions

Detailed Description

Visually impaired, with all corrections, individuals who have one tenth of the usual visual acuity of the seeing eye, i.e. 20/200 visual acuity or less, or whose visual angle does not exceed 20 degrees are called blind. The meaning of 20/200 is that an individual affected by visual impairment can see from 60 cm, while an individual with normal vision can see from 6 m. Narrow angle of vision means that, despite normal visual acuity, vision is limited only to the centre, 20 degrees, and objects beyond 20 degrees cannot be seen.

Balance depends on the integration of information received from proprioceptive, vestibular and visual sensory systems. It has been observed that visually impaired individuals have problems in postural stability and balance due to insufficient information from the visual system. In this study, it was aimed to compare the balance, coordination and gait parameters of congenitally visually impaired individuals and healthy sedentary individuals.

Study Type

Observational

Enrollment (Actual)

38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Ortahisar
      • Trabzon, Ortahisar, Turkey, 61000
        • Avrasya University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

In this study, congenitally visually impaired individuals and healthy individuals aged between 18-40 years were included.

Description

Inclusion Criteria:

  • 18 years of age or older
  • Congenital visual impairment
  • Not having any acute or chronic disease other than congenital blindness

Exclusion Criteria:

  • Having musculoskeletal deformity
  • Being involved in a professional sport
  • Having received physiotherapy treatment for balance before

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Congenitally blind
Individuals with congenital visual impairment were included in this group.
Healthy
Healthy sedentary individuals were included in this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Test
Time Frame: At the baseline of the study
Berg Balance Scale was developed for postural control assessment. It includes 14 instructions and for each instruction, the patient's performance is observed and a score between 0-4 is given. It takes between 10 and 20 minutes to complete the scale
At the baseline of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bahçeşehir University

Investigators

  • Study Director: Emine Atıcı, Assoc. Prof., Okan University
  • Principal Investigator: Alper Percin, Ph.D., Bahçeşehir University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 25, 2022

Primary Completion (Actual)

July 22, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

November 12, 2024

First Submitted That Met QC Criteria

November 12, 2024

First Posted (Estimated)

November 14, 2024

Study Record Updates

Last Update Posted (Estimated)

November 14, 2024

Last Update Submitted That Met QC Criteria

November 12, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Study0007

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It can be shared at the request of the researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blindness Congenital

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe